If you want a professional-looking logo for your business or blog but don’t have enough money to pay a graphic designer – or time to learn how to make it yourself – you’re in luck.

The best logo maker helps you craft the right branding for your business - even if you've never designed a logo before. Our team of expert reviewers have tested the best free logo makers and the ...

We waited more than a year for proper PWHL nicknames and logos. Now that we have them, courtesy of Monday’s official unveiling, we’re not going to waste any more time. Which of the six new ...

The company has a new logo, designed by Pentagram, that looks incredibly plain — especially compared to previous iterations of the logo that featured a rakish slant, two shades of blue ...

Genzyme of Cambridge, Massachusetts, faces millions in lost revenue from its top-selling specialty drugs Cerezyme and Fabrazyme as result of a viral contamination at its Allston, Massachusetts plant.

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

Sanofi has settled a long-running dispute with shareholders in the biotech Genzyme, who claimed the big pharma deliberately held back development of a multiple sclerosis drug to avoid payments ...

Read the lyrics to the new song "The Emptiness Machine" here. Linkin Park have revealed their new logo ahead of their exclusive event taking place in Los Angeles later this afternoon. While the ...

The company remains convinced of the product's merits and—bolstered by the backing of a $1.38 billion deal from Genzyme a year ago—continues to pursue cardiac and other autoimmune indications.

Anne Sugar is an executive coach and speaker who has advised top leaders at companies including TripAdvisor and Sanofi Genzyme. Anne serves as an executive coach for Harvard Business School Exec.

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for ...